Integrative Medicines (IM) Market - Regional Analysis
MEA Market Insights
The Middle East & Africa integrative medicines (IM) market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2035. The growth of the market can be attributed majorly to the rising prevalence of chronic disorders such as cancer, cardiovascular disorders, and neurological diseases in the region. By 2045, around 136 million people will have diabetes worldwide, with the MENA area having the greatest regional prevalence of nearly 16% and the second-highest predicted growth. Moreover, diabetes-related fatalities among adults of working age are most prevalent nearly 25%) in the MENA region. Furthermore, the rising use of integrative medicine is also expected to boost the market growth in the region. A study on the use of complementary and alternative medicine in Saudi Arabia in October 2020 states that around 74% of individuals used complementary and alternative medicine to address a variety of illnesses.
Europe Market Insights
Europe industry is predicted to hold largest revenue share of 30% by 2035, The market growth in the region is expected on the account of increasing cases of diabetes and the strong presence of leading integrative medicine service providers in the region. As per the Organization for Economic Cooperation and Development (OECD) analysis, approximately 32.3 million adults in the European Union were diagnosed with diabetes in the year 2019. The market in Europe is also anticipated to witness growth on account of the proven success of its healthcare providers in terms of therapy development.
